MICROMEDMARK
MicroMedMark is a biomedical company specialized in vitro diagnostic reagents and drug development services.
MICROMEDMARK
Industry:
Biotechnology Health Care Medical
Founded:
2008-08-19
Address:
Nanjing, Jiangsu, China
Country:
China
Website Url:
http://www.micromedmark.com
Total Employee:
11+
Status:
Active
Contact:
025-83517376
Total Funding:
3 M CNY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apache Apple Mobile Web App Capable DigiCert SSL Apple Mobile Web App Status Bar Style Mobile Optimized Encryption Everywhere Alibaba HiChina DNS
Investors List
Yinxinggu Capital
Yinxinggu Capital investment in Angel Round - MicroMedMark
Official Site Inspections
http://www.micromedmark.com
- Host name: 8.218.208.240
- IP address: 8.218.208.240
- Location: Singapore Singapore
- Latitude: 1.2929
- Longitude: 103.8547
- Timezone: Asia/Singapore
- Postal: 18
More informations about "MicroMedMark"
江苏命码生物科技有限公司
MicroMedMark 命码生物 江苏命码生物科技有限公司是基于张辰宇教授原创发现“细胞外微小核糖核酸稳定存在，具有独特的生物学功能”的科学规律，并在此基础上发展的基础研究、应用基 …See details»
MicroMedMark - Crunchbase Company Profile & Funding
MicroMedMark is a biomedical company specialized in vitro diagnostic reagents and drug development services. MicroMedMark develops basic research, applied basic research, …See details»
Jiangsu Mingma Biological Technology Co.,Ltd.
Explore Jiangsu Mingma Biological Technology Co.,Ltd. with its drug pipeline, therapeutic area, technology platform, 1 literature, Disease Domain:Neoplasms, Endocrinology and Metabolic …See details»
MicroMedMark - Funding, Financials, Valuation & Investors
MicroMedMark is a biomedical company specialized in vitro diagnostic reagents and drug development services.See details»
Jiangsu Mingma Biological Technology Co.,Ltd.
近日，2024年的诺贝尔医学或生理学奖颁给了发现microRNA的维克多·安布罗斯（Victor Ambros）和加里·鲁夫昆（Gary Ruvkun），本文就将汇总一些诺奖转化Biotech技术路线和研 …See details»
MicroMedMark - Crunchbase
MicroMedMark is a biomedical company specialized in vitro diagnostic reagents and drug development services.See details»
JIANGSU MICROMEDMARK BIOTECH CO., LTD. - US Patent and …
Apr 20, 2021 · Patent applications and USPTO patent grants for JIANGSU MICROMEDMARK BIOTECH CO., LTD..The latest application filed is for "k-ras gene expression-suppressing …See details»
命码检测 | 项目信息-36氪
命码检测是一家核酸诊断试剂产品研发商，自主研发的胰安tm——微小核糖核酸定性检测试剂盒，主要用于胰腺癌诊断领域，同时还提供实体肿瘤、感染、神经退行性疾病的诊断试剂盒。See details»
金斯瑞生物与命码生物签订协议，开展小核酸药物临床前合作医药 …
⌈ByDrug医药新闻摘要⌋ 2021-04-17 09:00，金斯瑞生物：2021年4月15日，金斯瑞生物与致力于开发小核酸药物的命码生物宣布，双方就小核酸药物临床前研究展开合作。 命码生物总裁贺宇 …See details»
Anti-BACT(Micromedmark Biotech Co., Ltd.) - Patsnap
Anti-BACT(Micromedmark Biotech Co., Ltd.), Initially developed by Jiangsu Mingma Biological Technology Co.,Ltd., Now, its global highest R&D status is Discontinued, Therapeutic Areas: …See details»
Anti-mHTT(Micromedmark Biotech Co., Ltd.) - Patsnap
We recently generated a nonhuman primate (NHP) model of the neurodegenerative disorder Huntington's disease (HD) using adeno-associated viral vectors to express a fragment of …See details»
MicroMedMark - Tech Stack, Apps, Patents & Trademarks
MicroMedMark is a biomedical company specialized in vitro diagnostic reagents and drug development services.See details»
Identification of Serum microRNA-25 as a novel biomarker for …
Dec 12, 2020 · To identify serum microRNA-25 (miR-25) as a diagnostic biomarker for pancreatic cancer (PCa) and to evaluate its supplementary role with serum carbohydrate antigen 19-9 …See details»
Therapeutic advances of miRNAs: A preclinical and clinical update
Feb 1, 2021 · The delivery system should be target-specific, and it should be able to deliver the drugs to the targeted cells or tissues. The biotechnology or pharmaceutical organization …See details»
Anti-KRAS(Micromedmark Biotech) - Drug Targets, Indications
Anti-KRAS (Micromedmark Biotech): a KRAS inhibitors Drug, Initially developed by Jiangsu Mingma Biological Technology Co.,Ltd., Now, its global highest R&D status is IND Application, …See details»
金斯瑞生物与命码生物签订协议，开展小核酸药物临床前合作 - 知乎
Apr 16, 2021 · 命码生物科学家团队经过将近10年的研究，开发出原创性颠覆性的第三代体内自组装核酸药物递送系统，其具有高生物利用率、低免疫原性和低毒性的特点。 本次合作开发的 …See details»
Anti-KRAS(Micromedmark Biotech)(Anti-KRAS(Micromedmark …
Anti-KRAS(Micromedmark Biotech): 一种KRAS抑制剂药物，由Jiangsu Mingma Biological Technology Co.,Ltd. (江苏命码生物科技有限公司)公司最早进行研发，目前全球最高研发状态为 …See details»
MIR-2911(MicroMedMark)-靶点_适应症: 埃博拉病毒性疾病-临床_ …
MIR-2911 (MicroMedMark)是由江苏命码生物科技有限公司研发的一种核苷类和核苷酸衍生物，目前该药物最高研发阶段为临床前，用于治疗埃博拉病毒性疾病、禽流感和新型冠状病毒感染。See details»
Anti-EGFR (Micromedmark Biotech) - Drug Targets, Indications
Herein, we report a novel anti-scFv aptamer-based biosensing system with high specificity and versatility. First, anti-scFv aptamers were screened using the competitive systematic evolution …See details»
anti-KRAS(MicroMedMark)-靶点: KRAS_适应症: 肺癌-临床_专利_批准
Anti-KRAS(MicroMedMark)是由江苏命码生物科技有限公司研发的一种核苷类和核苷酸衍生物，是一种KRAS抑制剂。目前该药物最高研发阶段为临床前，用于治疗肺癌和胰腺癌。See details»